Vice versa, transgenic overexpression of CREMα selectively in T cells results in reduced IL-2 expression [29], decreased pSTAT5 and IL4R levels and diminished TH2 type cytokines in vitro and in an asthma model in vivo. This evidence concerns the gene IL4R and asthma.